https://investor.ironwoodpharma.com/press-releases/press-release-details/2014/Ironwood-Pharmaceuticals-Announces-Initiation-of-Phase-II-Trial-of-Linaclotide-in-Adult-Patients-with-Opioid-Induced-Constipation/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- October 16, 2014